Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.510
+0.080 (5.59%)
May 8, 2026, 3:09 PM EDT - Market open
Invivyd Market Cap
Invivyd has a market cap or net worth of $427.03 million as of May 8, 2026. Its market cap has increased by 452.50% in one year.
Market Cap
427.03M
Enterprise Value
197.18M
1-Year Change
452.50%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $427.03M, a decrease of -81.15%. That is a compound annual growth rate of -29.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 404.41M | -40.92% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 452.12M |
| Atea Pharmaceuticals | 445.75M |
| Zura Bio | 444.99M |
| Autolus Therapeutics | 439.14M |
| Monopar Therapeutics | 427.03M |
| PureTech Health | 425.06M |
| Larimar Therapeutics | 421.76M |
| Benitec Biopharma | 420.31M |